Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.

Authors: Flandreau, Elizabeth I; Bourke, Chase H; Ressler, Kerry J; Vale, Wylie W; Nemeroff, Charles B; Owens, Michael J

Published In Psychoneuroendocrinology, (2013 Aug)

Abstract: We have previously demonstrated that viral-mediated overexpression of corticotropin-releasing factor (CRF) within the central nucleus of the amygdala (CeA) reproduces many of the behavioral and endocrine consequences of chronic stress. The present experiment sought to determine whether administration of the selective serotonin reuptake inhibitor (SSRI) escitalopram reverses the adverse effects of CeA CRF overexpression. In a 2×2 design, adult male rats received bilateral infusions of a control lentivirus or a lentivirus in which a portion of the CRF promoter is used to drive increased expression of CRF peptide. Four weeks later, rats were then implanted with an Alzet minipump to deliver vehicle or 10mg/kg/day escitalopram for a 4-week period of time. The defensive withdrawal (DW) test of anxiety and the sucrose-preference test (SPT) of anhedonia were performed both before and after pump implantation. Additional post-implant behavioral tests included the elevated plus maze (EPM) and social interaction (SI) test. Following completion of behavioral testing, the dexamethasone/CRF test was performed to assess HPA axis reactivity. Brains were collected and expression of HPA axis-relevant transcripts were measured using in situ hybridization. Amygdalar CRF overexpression increased anxiety-like behavior in the DW test at week eight, which was only partially prevented by escitalopram. In both CRF-overexpressing and control groups, escitalopram decreased hippocampal CRF expression while increasing hypothalamic and hippocampal expression of the glucocorticoid receptor (GR). These gene expression changes were associated with a significant decrease in HPA axis reactivity in rats treated with escitalopram. Interestingly, escitalopram increased the rate of weight gain only in rats overexpressing CRF. Overall these data support our hypothesis that amygdalar CRF is critical in anxiety-like behavior; because the antidepressant was unable to reverse behavioral manifestations of CeA CRF-OE. This may be a potential animal model to study treatment-resistant psychopathologies.

PubMed ID: 23267723 Exiting the NIEHS site

MeSH Terms: Amygdala/drug effects; Amygdala/metabolism*; Animals; Anxiety/genetics; Anxiety/metabolism; Behavior, Animal/drug effects; Body Weight/drug effects; Body Weight/genetics; Citalopram/pharmacology*; Corticotropin-Releasing Hormone/genetics; Corticotropin-Releasing Hormone/metabolism*; Dexamethasone; Gene Expression/drug effects; Hippocampus/drug effects; Hippocampus/metabolism; Hypothalamo-Hypophyseal System/drug effects*; Hypothalamo-Hypophyseal System/metabolism; Hypothalamus/drug effects; Hypothalamus/metabolism; Male; Pituitary-Adrenal Function Tests/methods; Pituitary-Adrenal System/drug effects*; Pituitary-Adrenal System/metabolism; Rats; Receptors, Glucocorticoid/metabolism; Serotonin Uptake Inhibitors/pharmacology

Back
to Top